Clostridioides difficile infection in Saudi Arabia: Prevalence, risk factors, and outcomes in a tertiary hospital setting
CDI prevalence reached 10.8% with an 11.4% recurrence rate. Acid-suppressant exposure and combination therapy were key recurrence signals, while metronidazole remains overused despite international guideline shifts. Enhanced antibiotic and acid-suppressant stewardship, alongside improved access to guideline-recommended therapies, are critical to reducing CDI burden in Saudi tertiary hospitals.
Authors
- Ahmed Muyidi
- Mohammed H. Makkawi
- Abdullah M. Aldhaif
- Mohammed A. Al-Garni
Institutions
- King Abdulaziz University (SA)
- King Fahd Medical City (SA)
- King Abdulaziz Hospital (SA)
- King Faisal University (SA)
- King Khalid University (SA)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-12-31
- DOI
- https://doi.org/10.1371/journal.pone.0340075
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- King Abdulaziz University